Global Artificial Insemination Market Size, Share, Forecast Report, 2020-2027

The artificial insemination is expected to register 11.8% CAGR during the forecast period of 2019 to 2025 and will achieve USD 1,943 million in 2025 with a market value of USD 1,726 million in 2018.

Artificial insemination is a treatment for infertility. It is a process involving the introduction of semen into the female reproductive tract. Artificial insemination has grown in popularity as infertility becomes more prevalent and more women opt to become single mothers.

Segmentation

The global artificial insemination has been segmented based on procedure, product type, and end-user. The global market, based on procedure, has been segmented into intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination sub-segment is expected to be the largest procedure type market as it increases the fertilization rate by inserting sperm inside the women’s uterus to facilitate fertilization. Intrauterine insemination is the most common and non-invasive procedure, which is expected to drive the growth of the global artificial insemination market.

The global market, by product type, has been classified into insemination kits, home conception devices, and accessories. Among this, the insemination kits segment is expected to be the fastest-growing segment in terms of value due to the growing geriatric population and is predicted to generate higher revenue during the forecast period.

The global market, based on end-user, has been segmented into hospitals and clinics, fertility centers, home care settings, and others. The fertility centers segment is expected to hold the largest share of the global market during the forecast period. Furthermore, major pharmaceutical companies are working on launching new insemination kits that have conventional benefits. This is expected to drive the growth of the global artificial insemination market.
Key Players

The key players operating in the global artificial insemination market are INVO Bioscience, MEDGYN PRODUCTS, INC., FUJIFILM Irvine Scientific., Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC., and HI-TECH Solutions.

Global Artificial Insemination Market, by Procedure

• Intrauterine Insemination
• Intracervical Insemination
• Intratubal Insemination

Global Artificial Insemination Market by Product Type

• Insemination Kits
• Home Conception Devices
• Accessories

Global Artificial Insemination Market, by End User

• Hospital & Clinics
• Fertility Centers
• Home Care Settings
• Others